A new trading day began on Tuesday, with BioAtla Inc (NASDAQ: BCAB) stock price down -3.70% from the previous day of trading, before settling in for the closing price of $0.86. BCAB’s price has ranged from $0.24 to $1.74 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -10.97% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 26.04%. With a float of $45.63 million, this company’s outstanding shares have now reached $58.79 million.
BioAtla Inc (BCAB) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of BioAtla Inc is 22.39%, while institutional ownership is 15.75%.
BioAtla Inc (BCAB) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.3 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.04% per share during the next fiscal year.
BioAtla Inc (NASDAQ: BCAB) Trading Performance Indicators
Here are BioAtla Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.79 in one year’s time.
Technical Analysis of BioAtla Inc (BCAB)
Let’s dig in a bit further. During the last 5-days, its volume was 3.28 million. That was better than the volume of 0.92 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 28.47%.
During the past 100 days, BioAtla Inc’s (BCAB) raw stochastic average was set at 45.27%, which indicates a significant increase from 27.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1853 in the past 14 days, which was higher than the 0.0832 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7577, while its 200-day Moving Average is $0.4929. However, in the short run, BioAtla Inc’s stock first resistance to watch stands at $0.8808. Second resistance stands at $0.9363. The third major resistance level sits at $1.0154. If the price goes on to break the first support level at $0.7462, it is likely to go to the next support level at $0.6671. The third support level lies at $0.6116 if the price breaches the second support level.
BioAtla Inc (NASDAQ: BCAB) Key Stats
With a market capitalization of 48.53 million, the company has a total of 58,792K Shares Outstanding. Currently, annual sales are 11,000 K while annual income is -69,780 K. The company’s previous quarter sales were 0 K while its latest quarter income was -15,780 K.
